Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 High-dose olanzapine orally disintegrating tablets for treatment-resistant psychosis.

Literature DB >> 16964322

High-dose olanzapine orally disintegrating tablets for treatment-resistant psychosis.

S Faiz Qadri, Prasad R Padala, J Chris Strunk, Susan J Boust.

Abstract

Entities: Chemical Disease

Year: 2006 PMID： 16964322 PMCID： PMC1557475 DOI： 10.4088/pcc.v08n0410a

Source DB: PubMed Journal: Prim Care Companion J Clin Psychiatry ISSN： 1523-5998

× No keyword cloud information.

8 in total

1. Use of high-dose olanzapine in refractory psychosis.

Authors: J Reich
Journal: Am J Psychiatry Date: 1999-04 Impact factor: 18.112

Review 2. Antipsychotic-induced weight gain: a comprehensive research synthesis.

Authors: D B Allison; J L Mentore; M Heo; L P Chandler; J C Cappelleri; M C Infante; P J Weiden
Journal: Am J Psychiatry Date: 1999-11 Impact factor: 18.112

3. British experience with high-dose olanzapine for treatment-refractory schizophrenia.

Authors: C Q Mountjoy; A M Baldacchino; J H Stubbs
Journal: Am J Psychiatry Date: 1999-01 Impact factor: 18.112

4. An assessment of the independent effects of olanzapine and risperidone exposure on the risk of hyperlipidemia in schizophrenic patients.

Authors: Carol E Koro; Donald O Fedder; Gilbert J L'Italien; Sheila Weiss; Laurence S Magder; Julie Kreyenbuhl; Dennis Revicki; Robert W Buchanan
Journal: Arch Gen Psychiatry Date: 2002-11

5. Differential effects of risperidone, olanzapine, clozapine, and conventional antipsychotics on type 2 diabetes: findings from a large health plan database.

Authors: Frank D Gianfrancesco; Amy L Grogg; Ramy A Mahmoud; Ruey-hua Wang; Henry A Nasrallah
Journal: J Clin Psychiatry Date: 2002-10 Impact factor: 4.384

6. High-dose olanzapine for treatment-refractory schizophrenia.

Authors: Vladimir Lerner
Journal: Clin Neuropharmacol Date: 2003 Mar-Apr Impact factor: 1.592

7. Switching treatment-resistant patients with schizophrenia or schizoaffective disorder to olanzapine: a one-year open-label study with five-year follow-up.

Authors: James L Karagianis; Kellie K LeDrew; Daniel J Walker
Journal: Curr Med Res Opin Date: 2003 Impact factor: 2.580

8. Radioreceptor binding profile of the atypical antipsychotic olanzapine.

Authors: F P Bymaster; D O Calligaro; J F Falcone; R D Marsh; N A Moore; N C Tye; P Seeman; D T Wong
Journal: Neuropsychopharmacology Date: 1996-02 Impact factor: 7.853